GUMDROP : JHMI J1128 A Phase II Trial of STA 9090 in Patients with Metastatic Castration Resistant Prostate Cancer Pretreated with Docetaxel Based Chemotherapy

Created by Channing Paller, last modified on Apr 14, 2012

Description:

CRPC with at least one prior docetaxel based regimen for metastatic dx; no maximum prior therapy; testosterone < 50 ng/dl; NO current or prior radiation to the left hemithorax

Link:

http://clinicaltrials.gov/ct2/show/NCT01270880

Site:

Johns Hopkins Hospital

Principal Investigator:

Emmanuel Antonarakis, M.D.